Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy involving diuretics and amiodarone. Diuretics are a class of medications that promote the excretion of water and electrolytes from the kidneys, commonly used to manage hypertension, edema, and heart failure. Amiodarone is a class III antiarrhythmic agent that works by blocking potassium channels in cardiac tissue, prolonging repolarization and stabilizing abnormal heart rhythms. The combination may be used in patients with arrhythmias who also require fluid management; however, this combination carries an increased risk of adverse effects such as electrolyte disturbances (notably hypokalemia or hypomagnesemia), which can potentiate the proarrhythmic effects of amiodarone[1][3][4]. This combination should be used with caution under close medical supervision.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diuretics + amiodarone.